BioHealth News Archive
Meet the woman who helped develop Johns Hopkins’ coronavirus map | Coronavirus | kctv5.com
Many policy decisions on the pandemic -- in Washington and locally -- are driven by an online data tool developed at Johns Hopkins University.…
Read More
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia
PLYMOUTH MEETING, Pa. and GERMANTOWN, Md. and HILDEN, Germany, Feb. 24, 2021 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ:…
Read More
New lab space in the works for downtown Richmond as pharmaceutical development company Phlow forms strategic alliance | Business News | richmond.com
Richmond-based pharmaceutical development company Phlow Corp. has formed a partnership with a nonprofit organization that will involve opening new laboratory operations in downtown Richmond.…
Read More
DARPA opens door to more private equity-backed firms — Washington Technology
The Defense Advanced Research Projects Agency will now allow small businesses that are majority owned by private equity firms to bid on both Small…
Read More
Meet the Daily Record’s Power 100 – Maryland Daily Record
Congratulations to the BHI Board-members who made the list. Pete Briskman - Executive Managing Director Maryland , JLL Ron Daniels - President, Johns Hopkins University Dr.…
Read More
Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center
The LaunchPort™ announced today that Novel Microdevices (http://www.noveldx.com) has moved to their Medtech venture center in Port Covington, Baltimore, and has established The LaunchPort™…
Read More
IP Costs Associated with SBIR and STTR | Kilpatrick Townsend & Stockton LLP – JDSupra
The National Institutes of Health (NIH) small business programs, which include the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer (STTR)…
Read More
Georgetown Ranks Second Among Top Universities in Women Graduates Who Enter Venture Capital
Georgetown University ranks second among the nation’s colleges and universities in graduating women who go on to lead venture capital firms, according to a…
Read More
Phlow Corp. and USP announce strategic alliance focused on Pharmaceutical Continuous Manufacturing to increase supply of essential medicines for U.S. patients
Richmond, VA., February 22, 2021 – Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a…
Read More
VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-18, 2021
Don’t miss a unique opportunity to discuss your biohealth technology innovation directly with Program Officers from NSF, various institutes at NIH (including NIA, NCI,…
Read More
VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)
Don’t miss a unique opportunity to discuss your biohealth technology innovation directly with Program Officers from NSF, various institutes at NIH, the University of…
Read More
2/28 Deadline to Apply for $ (oncology innovation)…
for The Rockville-based National Foundation for Cancer Research is accepting applications through Sunday evening, February 28, from academic laboratory and early stage start-up-based promising…
Read More
Salisbury Award for Entrepreneurial Translational Research – NFCR
The National Foundation for Cancer Research is proud to present the Salisbury Award in honor of the Salisbury family’s vision and legacy of funding…
Read More
Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer – Cartesian
Gaithersburg, MD, Feb. 22, 2021 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering mRNA-engineered cell therapy in and beyond oncology, today announced that…
Read MoreNovavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico | Novavax Inc. – IR Site
GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…
Read More